BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fitzpatrick ME, Kunisaki KM, Morris A. Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy. AIDS 2018;32:277-92. [PMID: 29194119 DOI: 10.1097/QAD.0000000000001712] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Manaenkova TL, Bairova TA, Sambyalova AY, Paramonov AI, Belyaeva EV, Bugun OV, Rychkova LV. Comorbid disease in children and adolescents with perinatal HIV infection: A pilot study. Acta biomedica scientifica 2022;7:74-85. [DOI: 10.29413/abs.2022-7.5-2.8] [Reference Citation Analysis]
2 Naranjo O, Torices S, Clifford PR, Daftari MT, Osborne OM, Fattakhov N, Toborek M. Pericyte infection by HIV-1: a fatal attraction. Retrovirology 2022;19:27. [PMID: 36476484 DOI: 10.1186/s12977-022-00614-3] [Reference Citation Analysis]
3 Dean LS, Chow DC, Ndhlovu LC, Boisvert WA, Chang SP, Shikuma CM, Park J. Characterization of Circulating Fibrocytes in People Living with HIV on Stable Antiretroviral Therapy. Immunohorizons 2022;6:760-7. [PMID: 36445359 DOI: 10.4049/immunohorizons.2200085] [Reference Citation Analysis]
4 Spinelli MA, Jones BLH, Gandhi M. COVID-19 Outcomes and Risk Factors Among People Living with HIV. Curr HIV/AIDS Rep 2022. [PMID: 35930187 DOI: 10.1007/s11904-022-00618-w] [Reference Citation Analysis]
5 Titanji BK, Gwinn M, Marconi VC, Sun YV. Epigenome-wide epidemiologic studies of human immunodeficiency virus infection, treatment, and disease progression. Clin Epigenetics 2022;14:8. [PMID: 35016709 DOI: 10.1186/s13148-022-01230-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Read N, Lipman M. Human Immunodeficiency Virus. Encyclopedia of Respiratory Medicine 2022. [DOI: 10.1016/b978-0-08-102723-3.00179-7] [Reference Citation Analysis]
7 Matiza T, Boyd KF, Lyall RA, Kwon DS, McGregor AM, Fiorillo S, Campbell TB, Borok M, Corleis B. Compartmentalized T cell profile in the lungs of patients with HIV-1-associated pulmonary Kaposi sarcoma. Medicine (Baltimore) 2021;100:e28328. [PMID: 34941134 DOI: 10.1097/MD.0000000000028328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang H, Jonas KJ. The likelihood of severe COVID-19 outcomes among PLHIV with various comorbidities: a comparative frequentist and Bayesian meta-analysis approach. J Int AIDS Soc 2021;24:e25841. [PMID: 34797952 DOI: 10.1002/jia2.25841] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zifodya JS, Triplette M, Shahrir S, Attia EF, Akgun KM, Soo Hoo GW, Rodriguez-Barradas MC, Wongtrakool C, Huang L, Crothers K. A cross-sectional analysis of diagnosis and management of chronic obstructive pulmonary disease in people living with HIV: Opportunities for improvement. Medicine (Baltimore) 2021;100:e27124. [PMID: 34664836 DOI: 10.1097/MD.0000000000027124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 van Riel SE, Klipstein-Grobusch K, Barth RE, Grobbee DE, Feldman C, Shaddock E, Stacey SL, Venter WDF, Vos AG. Predictors of impaired pulmonary function in people living with HIV in an urban African setting. South Afr J HIV Med 2021;22:1252. [PMID: 34522426 DOI: 10.4102/sajhivmed.v22i1.1252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Viktorova IB, Khanin AL, Zimina VN, Dadyka IV, Gorjaeva MO. Chronic obstructive pulmonary disease in patients infected with human immunodeficiency virus. Pulʹmonologiâ (Mosk ) 2021;31:477-482. [DOI: 10.18093/0869-0189-2021-31-4-477-482] [Reference Citation Analysis]
12 Harrington KRV, Staitieh BS, Nguyen MLT, Colasanti JA, Sumitani J, Marconi VC, Auld SC. Diagnosis and Management of HIV-Associated Pulmonary Diseases in a Ryan White-Funded Primary Care Setting. AIDS Patient Care STDS 2021;35:239-48. [PMID: 34242091 DOI: 10.1089/apc.2021.0020] [Reference Citation Analysis]
13 Jiménez M, Cervantes-García D, Córdova-Dávalos LE, Pérez-Rodríguez MJ, Gonzalez-Espinosa C, Salinas E. Responses of Mast Cells to Pathogens: Beneficial and Detrimental Roles. Front Immunol 2021;12:685865. [PMID: 34211473 DOI: 10.3389/fimmu.2021.685865] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
14 Jan AK, Moore JV, Wang RJ, Mcging M, Farr CK, Moisi D, Hartman-Filson M, Kerruish R, Jeon D, Lewis E, Crothers K, Lederman MM, Hunt PW, Huang L. Markers of inflammation and immune activation are associated with lung function in a multi-center cohort of persons with HIV. AIDS 2021;35:1031-40. [PMID: 33635847 DOI: 10.1097/QAD.0000000000002846] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
15 Nachega JB, Kapata N, Sam-Agudu NA, Decloedt EH, Katoto PDMC, Nagu T, Mwaba P, Yeboah-Manu D, Chanda-Kapata P, Ntoumi F, Geng EH, Zumla A. Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa. Int J Infect Dis 2021:S1201-9712(21)00256-3. [PMID: 33757874 DOI: 10.1016/j.ijid.2021.03.038] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
16 Abdu M, Ali Y, Anteneh S, Yesuf M, Birhanu A, Mohamed S, Hussien A. Determinant factors for the occurrence of tuberculosis after initiation of antiretroviral treatment among adult patients living with HIV at Dessie Referral Hospital, South Wollo, Northeast Ethiopia, 2020. A case-control study. PLoS One 2021;16:e0248490. [PMID: 33724992 DOI: 10.1371/journal.pone.0248490] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Jespersen NA, Axelsen F, Dollerup J, Nørgaard M, Larsen CS. The burden of non-communicable diseases and mortality in people living with HIV (PLHIV) in the pre-, early- and late-HAART era. HIV Med 2021;22:478-90. [PMID: 33645000 DOI: 10.1111/hiv.13077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
18 Linfield DT, Raduka A, Aghapour M, Rezaee F. Airway tight junctions as targets of viral infections. Tissue Barriers 2021;9:1883965. [PMID: 33632074 DOI: 10.1080/21688370.2021.1883965] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
19 Viktorova IB, Zimina VN, Kravchenko AV. Chronic obstructive pulmonary disease and HIV-infection. VIČ-infekc immunosupr 2021;12:23-31. [DOI: 10.22328/2077-9828-2020-12-4-23-31] [Reference Citation Analysis]
20 Lorenz DR, Misra V, Chettimada S, Uno H, Wang L, Blount BC, De Jesús VR, Gelman BB, Morgello S, Wolinsky SM, Gabuzda D. Acrolein and other toxicant exposures in relation to cardiovascular disease among marijuana and tobacco smokers in a longitudinal cohort of HIV-positive and negative adults. EClinicalMedicine 2021;31:100697. [PMID: 33554087 DOI: 10.1016/j.eclinm.2020.100697] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Auld SC, Kornfeld H, Maenetje P, Mlotshwa M, Chase W, Vangu MD, Torigian DA, Wallis RS, Churchyard G, Bisson GP. Pulmonary restriction predicts long-term pulmonary impairment in people with HIV and tuberculosis. BMC Pulm Med 2021;21:19. [PMID: 33413293 DOI: 10.1186/s12890-020-01368-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Brown LB, Spinelli MA, Gandhi M. The interplay between HIV and COVID-19: summary of the data and responses to date. Curr Opin HIV AIDS 2021;16:63-73. [PMID: 33186229 DOI: 10.1097/COH.0000000000000659] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 32.0] [Reference Citation Analysis]
23 Hessol NA, Barrett BW, Margolick JB, Plankey M, Hussain SK, Seaberg EC, Massad LS. Risk of smoking-related cancers among women and men living with and without HIV. AIDS 2021;35:101-14. [PMID: 33048871 DOI: 10.1097/QAD.0000000000002717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Roychoudhury S, Das A, Sengupta P, Dutta S, Roychoudhury S, Choudhury AP, Ahmed ABF, Bhattacharjee S, Slama P. Viral Pandemics of the Last Four Decades: Pathophysiology, Health Impacts and Perspectives. Int J Environ Res Public Health 2020;17:E9411. [PMID: 33333995 DOI: 10.3390/ijerph17249411] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
25 Byanova K, Kunisaki KM, Vasquez J, Huang L. Chronic obstructive pulmonary disease in HIV. Expert Rev Respir Med 2021;15:71-87. [PMID: 33167728 DOI: 10.1080/17476348.2021.1848556] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
26 Marone G, Rossi FW, Pecoraro A, Pucino V, Criscuolo G, Paulis A, Spadaro G, Marone G, Varricchi G. HIV gp120 Induces the Release of Proinflammatory, Angiogenic, and Lymphangiogenic Factors from Human Lung Mast Cells. Vaccines (Basel) 2020;8:E208. [PMID: 32375243 DOI: 10.3390/vaccines8020208] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
27 Stek C, Allwood B, Du Bruyn E, Buyze J, Schutz C, Thienemann F, Lombard A, Wilkinson RJ, Meintjes G, Lynen L. The effect of HIV-associated tuberculosis, tuberculosis-IRIS and prednisone on lung function. Eur Respir J 2020;55:1901692. [PMID: 31862762 DOI: 10.1183/13993003.01692-2019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
28 Lorenz DR, Misra V, Gabuzda D. Transcriptomic analysis of monocytes from HIV-positive men on antiretroviral therapy reveals effects of tobacco smoking on interferon and stress response systems associated with depressive symptoms. Hum Genomics 2019;13:59. [PMID: 31779701 DOI: 10.1186/s40246-019-0247-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
29 Lehmann MH, Lehmann JM, Erfle V. Nef-induced CCL2 Expression Contributes to HIV/SIV Brain Invasion and Neuronal Dysfunction. Front Immunol 2019;10:2447. [PMID: 31681324 DOI: 10.3389/fimmu.2019.02447] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
30 Kummerow M, Shaddock EJ, Klipstein-Grobusch K, Barth RB, Grobbee DE, Venter FDF, Feldman C, Vos A. Unexpected low frequency of respiratory symptoms in an HIV-positive urban sub-Saharan population compared to an HIV-negative control group. South Afr J HIV Med 2019;20:1010. [PMID: 31616576 DOI: 10.4102/sajhivmed.v20i1.1010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
31 Watson WH, Ritzenthaler JD, Peyrani P, Wiemken TL, Furmanek S, Reyes Vega AM, Burke TJ, Zheng Y, Ramirez JA, Roman J. Plasma cysteine/cystine and glutathione/glutathione disulfide redox potentials in HIV and COPD patients. Free Radic Biol Med 2019;143:55-61. [PMID: 31369840 DOI: 10.1016/j.freeradbiomed.2019.07.031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
32 Robertson TE, Nouraie M, Qin S, Crothers KA, Kessinger CJ, McMahon D, Chandra D, Kingsley LA, Greenblatt RM, Huang L, Fitzpatrick ME, Morris A. HIV infection is an independent risk factor for decreased 6-minute walk test distance. PLoS One 2019;14:e0212975. [PMID: 31017909 DOI: 10.1371/journal.pone.0212975] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Lorenz DR, Uno H, Wolinsky SM, Gabuzda D. Effect of marijuana smoking on pulmonary disease in HIV-infected and uninfected men: a longitudinal cohort study. EClinicalMedicine 2019;7:55-64. [PMID: 30854514 DOI: 10.1016/j.eclinm.2019.01.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]